Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Etoposide + Ifosfamide |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Etoposide | Vepesid | EPEG|Eposin|VP-16|VP-16-213 | TOPO2 inhibitor 5 | Vepesid (etoposide) binds to and inhibits DNA topoisomerase II, resulting in accumulated DNA damage, inhibition of replication, and cell death (NCI Drug Dictionary). |
Ifosfamide | Cyfos | Z4942 | Chemotherapy - Alkylating 18 | Cyfos (ifosfamide) is an alkylating agent, which cross-links DNA, thereby inhibiting DNA replication (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01505569 | Phase I | Filgrastim Busulfan + Melphalan Etoposide + Ifosfamide Thiotepa Carboplatin | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors | Completed | USA | 0 |
NCT04154189 | Phase II | Etoposide + Ifosfamide Etoposide + Ifosfamide + Lenvatinib | A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma | Completed | USA | SWE | NZL | NLD | ITA | ISR | IRL | GBR | FRA | FIN | ESP | CZE | CHE | CAN | BEL | AUT | AUS | 4 |
NCT00936936 | Phase II | Gemcitabine Ifosfamide Etoposide Melphalan Etoposide + Ifosfamide Docetaxel + Gemcitabine + Melphalan Bevacizumab + Carboplatin | High-dose Chemotherapy for Poor-prognosis Relapsed Germ-Cell Tumors | Completed | USA | 0 |